Skip to content

Evaluation of A Partially Hydrolyzed in Improving FGIDs Symptoms

Evaluation of A Partially Hydrolyzed Whey Protein Infant Formula in Improving Functional Gastrointestinal Disorders (FGIDs) Symptoms

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03390309
Enrollment
0
Registered
2018-01-04
Start date
2018-07-05
Completion date
2019-06-28
Last updated
2018-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Gastrointestinal Disorders

Brief summary

Evaluation of A Partially Hydrolyzed Whey Protein Infant Formula in Improving Functional Gastrointestinal Disorders (FGIDs) Symptoms

Detailed description

This study will investigate the prevalence of Shanghai area's infant with FGIDs symptom and contrast for the FGIDs symptoms by using different intervention means, and evaluate the effectiveness of FGIDs symptoms in infants by using partially hydrolyzed whey protein and low lactose infant formulation.

Interventions

Partially Hydrolyzed Whey Protein Infant Formula

OTHERNormal Formula

Normal Formula

Sponsors

Children's Hospital of Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to 6 Months
Healthy volunteers
Yes

Inclusion criteria

* Infants is formula-fed or mixed feeding a cow milk protein-based formula for less 7 days prior to enrollment. * Infant is between 30-180 days of age. * Infant's parent(s) or Legally authorized representative(LAR) has voluntarily signed and dated an informed consent form (ICF), approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) prior to any participation in the study.

Exclusion criteria

* Complementary food was added for infants or parents are willing to add complementary food during study. * Suffer from infection/illness. * Infant has suspected or known metabolic or physical diseases affecting infant feeding and/or metabolism. * Infant has visible bloody stools (detected before enrollment) prior to enrollment. * Participation in another study.

Design outcomes

Primary

MeasureTime frameDescription
Change of total symptom score of infant feeding & stool pattern questionnaire.From enrollment to end of treatment(1 week). The scores will be measured at the following time point: enrollment,end of treatment(one week after the start of treatment).Investigator report questionnaire. Total score consists of 6 sub scores based on different symptom scaleing : diarrhea(0= no; 1= yes), constipation(0= no; 1= yes), galactorrhea/spit milk(0= no; 1= yes), Irritability or crying(0= no; 0.5= yes), bloating/ tummy drum/ exhaust(0= no; 1= yes), other(0= no, 0.5=yes).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026